The average EPS estimate for EXACT Sciences Corporation (NASDAQ:EXAS) for the three months ending 2016-12-31 is given as $-0.43.
You find that 7 days ago, the average EPS estimate on the stock was $-0.43, while for the 30 days ago the average EPS estimate stood at $-0.43.
If you look back further, you see that the average EPS estimate for EXACT Sciences Corporation (NASDAQ:EXAS) 60 days ago was given as -0.43, while EPS estimate 90 days ago was quoted at $-0.43.
The change in the stock’s EPS estimate over the last 7 days works out to 0%.
EPS estimate revisions
Over the last 7 days, EPS estimates for EXACT Sciences Corporation (NASDAQ:EXAS) have been revised up 0 times. In the same period, the EPS estimate has been revised down 0 times.
In the last 30 days, the stock has had its EPS estimate revised up 5 and it has been revised up 5 times over the last 60 days.
Up revisions in the last 90 days are 5 and up revisions in the last 120 days are 5.
But for the last 18 days, the company has seen its EPS revised up 2 times, offset by 3 down revisions in the same period.
The down revisions of EPS in last 30, 60, 90 and 120 days were 1, 1, 1 and 1.
What About EPS Surprises
Analysts predicted EPS of $-0.43 for EXACT Sciences Corporation (NASDAQ:EXAS) for the period ended 2. But the company ended up posting actual EPS of $-0.46 on 2016-07-26. The EPS estimate cited was worked out based on 6 estimates that analysts had issued on the stock.
Therefore, EXACT Sciences Corporation (NASDAQ:EXAS) posted EPS surprise of $0.09 per share in dollar terms, which works out to 16.36%. The standard deviation of the actual EPS reported by the company and the average EPS estimate immediately before the earnings were released works out to $0.01.
Quarterly Sales Estimates
For the fiscal year 2017, the mean and median annual sales estimates for the company are given as $44.48 and $41.54. The estimates are based on the projections of 3 analysts.
So far, the highest annual sales estimate for EXACT Sciences Corporation (NASDAQ:EXAS) stands at$51.6. That compares with the lowest annual sales estimate of $40.3. Calculating the standard deviation of the extreme annual sales estimates leads you to 6.197%.
Annual sales estimate adjustments
In the last 7 days, 3 analysts have raised their annual sales estimates for the company. But over the same period, 3 analysts have trimmed their annual sales estimates.
With that, you find that the percentage change in mean annual sales estimate in the last 7 days works out to 0%.
Over the last one month, though, 3 analysts moved to raise their sales estimates for EXACT Sciences Corporation (NASDAQ:EXAS). That compares with 3 analysts who cut their sales estimate for the company in the same period. That leads you to 11.534% as the mean sales estimate change over the last one month.
If you look back further, you see that over the last three months, 3 analysts have moved raise their sales estimates EXACT Sciences Corporation (NASDAQ:EXAS). That offset by 3 analysts who in the same period lowered their sales estimates for the stock. That works out to percentage change in mean sales estimate of 13.46% over a period of three months.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...